Teva

BLEOMYCIN SULFATE

  1. Home
  2.  / 
  3. J Code
  4.  / BLEOMYCIN SULFATE – J9040

Manufacturer:

Teva

Name:

BLEOMYCIN SULFATE

HCPCS Code Descriptor:

Injection, bleomycin sulfate, 15 units

Category:

J Code

HCPCS:

J9040

NDC(s):

71288-0107-20, 71288-0106-10, 63323-0136-10, 63323-0137-20, 61703-0332-18, 61703-0323-22, 16714-0908-01, 16714-0886-01, 00703-3155-01, 00703-3154-01, 00409-0332-20, 00409-0323-20, 00143-9240-01, 00143-9241-01

Primary Type:

Oncology

Generic Status:

Multi-Source

Route of Administration:

Injection

About:

BLEOMYCIN SULFATE is an Oncology drug manufactured by Teva and administered via the Injection route of administration. The J Code: J9040 is aligned to the drug BLEOMYCIN SULFATE.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/84

HCPCS Effective Date:

1/1/09

HCPCS Short Description:

Bleomycin sulfate injection

Billing and Coding Guide:

Not Found

Patient Assistance:

Not Found